Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Nihon Medi-Physics Embarks on Development of New Cancer Treatment

Filed Under: Innovation, Pharma Tagged With: , , , , , , , , ,

Nihon Medi-Physics Co. Ltd., a radiopharmaceutical manufacturing venture equally funded by Sumitomo Chemical Co. Ltd. (TYO:4005) and GE Healthcare, will…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Tokyo Tech Works on New Form of Photodynamic Cancer Treatment
Tokyo Tech Works on New Form of Photodynamic Cancer…
Tokyo Tech Devises a New Generation of BPA for Use in Chemical Surgery
Tokyo Tech Devises a New Generation of BPA for Use in…
Coronavirus Report – Part 13: Japanese Companies Start to Develop Vaccines, Treatments
Coronavirus Report – Part 13: Japanese Companies Start to…
Ai-Carbon Develops Method for Easy Recycling of Carbon Fiber at Normal Temperature
Ai-Carbon Develops Method for Easy Recycling of Carbon Fiber…
Omega Develops World-First System for Complete Waste Liquid Treatment in Chemical Plants
Omega Develops World-First System for Complete Waste Liquid…